Galapagos NV ADR (GLPG) - Stock Price & Dividends

Exchange: USA Stocks • Country: Belgium • Currency: USD • Type: Common Stock • ISIN: US36315X1019

Galapagos NV, listed asGLPG on NASDAQ, is an innovative biopharmaceutical company based in Mechelen, Belgium. Since its establishment in 1999, the company has been dedicated to discovering, developing, and bringing to market a range of medicines to address critical medical needs.

Among its notable pipeline productsis filgotinib, which holds promise as a JAK1 inhibitor undergoing clinical trials for conditions such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and uveitis. Additionally, the company's pipeline includes GLPG3667, which has completed Phase 1b trials, alongside pioneering products like GLPG5101 and GLPG5201 - advanced CD19 CAR-T therapies produced at the point-of-care, currently undergoing Phase I/II trials for relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Galapagos NV has forged strategic collaborations with industry leaders like Gilead Sciences, Inc., AbbVie S.à r.l., and Novartis Pharma AG to further enhance the development and commercialization of its groundbreaking therapeutics. For more information on Galapagos NV and its transformative work in the biopharmaceutical realm, visit their website: https://www.glpg.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Galapagos NV ADR (GLPG) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Galapagos NV ADR (GLPG) - Stock Price & Dividends

GLPG Stock Overview

Market Cap in USD 2,172m
Sector Healthcare
Industry Biotechnology
GiC SubIndustry Biotechnology
TER 0.00%
IPO / Inception 2005-05-06

GLPG Stock Ratings

Growth 5y -6.13
Fundamental -5.00
Dividend -
Rel. Performance vs Sector -3.12
Analysts 3.43/5
Fair Price Momentum 21.80 USD
Fair Price DCF -

GLPG Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

GLPG Growth Ratios

Growth 12m -22.60%
Growth Correlation 12m -45%
Growth Correlation 3m -73%
CAGR 5y -23.84%
Sharpe Ratio 12m -1.08
Alpha vs SP500 12m -45.03
Beta vs SP500 5y weekly 0.99
ValueRay RSI 4.08
Volatility GJR Garch 1y 27.55%
Price / SMA 50 -15.67%
Price / SMA 200 -21.49%
Current Volume 192.8k
Average Volume 20d 143.1k

External Links for GLPG Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of GLPG stocks?
As of April 18, 2024, the stock is trading at USD 29.22 with a total of 192,831 shares traded.
Over the past week, the price has changed by -6.11%, over one month by -12.54%, over three months by -24.50% and over the past year by -23.31%.
What is the forecast for GLPG stock price target?
According to ValueRays Forecast Model, GLPG Galapagos NV ADR will be worth about 24.3 in April 2025. The stock is currently trading at 29.22. This means that the stock has a potential downside of -17.01%.
Issuer Forecast Upside
Wallstreet Target Price 43.6 49.1%
Analysts Target Price 46.9 60.5%
ValueRay Target Price 24.3 -17.0%